Multidrug-resistance drug-binding peptides generated by using a phage display library

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• P-glycoprotein (P-gp) is a key transporter protein involved in multidrug resistance (MDR).
• Understanding P-gp's drug-binding mechanisms is crucial for developing effective cancer therapies.
• Phage display technology offers a powerful tool for identifying novel peptide ligands.

Purpose of the Study:

• To generate peptide ligands capable of binding multidrug-resistance (MDR) drugs.
• To mimic the drug-binding activity of P-glycoprotein using peptide ligands.
• To explore the potential of these peptides in the design of new chemotherapeutic agents.

Main Methods:

• Utilized a phage display library of random decapeptides to identify peptide ligands.
• Performed binding assays to detect specific interactions with doxorubicin and other MDR drugs.
• Employed structure modeling to analyze the binding mechanism of the identified peptides.
• Conducted Western blot analysis to confirm the recognition of P-glycoprotein by specific antibodies.

Main Results:

• Identified seven peptide sequences that specifically bind doxorubicin, with five featuring a WXXW motif.
• Demonstrated that selected peptides exhibit similar drug-binding selectivity to P-glycoprotein for MDR drugs.
• Synthesized a high-affinity peptide (VCDWWGWGIC) that competes for doxorubicin binding.
• Structure modeling indicated a hydrophobic envelope suitable for docking MDR drugs.
• Developed a monospecific antibody recognizing P-glycoprotein in MDR cells using a selected peptide.

Conclusions:

• Generated novel peptide sequences that effectively bind MDR drugs, mimicking P-glycoprotein.
• These peptide ligands represent a valuable tool for screening and designing new chemotherapeutic agents.
• The findings provide insights into P-gp drug-binding interactions and potential therapeutic strategies.